Publication | Closed Access

Co-delivery of Se nanoparticles and pooled SiRNAs for overcoming drug resistance mediated by P-glycoprotein and class III β-tubulin in drug-resistant breast cancers

NanomedicineDrug TargetingEngineeringHealth SciencesClass Iii β-TubulinSe NanoparticlesPharmaceutical NanotechnologyBreast CancerTumor TargetingNano-drug DeliveryPharmacologyRadiation OncologyBiomolecular EngineeringDrug Resistance